Form D — Evogene Ltd.
0001178913-26-000573 · filed Feb 19, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $3,384,616
- Total sold
- $3,384,616
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Evogene Ltd.
- CIK
- 1574565
- Entity
- Corporation
- Jurisdiction
- ISRAEL
- Year incorporated
- —
- Address
- 13 GAD FEINSTEIN STREET
REHOVOT, L3 7638517 - Phone
- 97289311900
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ofer Haviv · Executive OfficerRehovot, L3 Find on LinkedIn ↗
-
Yaron Eldad · Executive OfficerRehovot, L3 Find on LinkedIn ↗
-
Gabi Tarcic · Executive OfficerRehovot, L3 Find on LinkedIn ↗
-
Ilia Zhidkov · Executive OfficerRehovot, L3 Find on LinkedIn ↗
-
Nir Nimrodi · DirectorRehovot, L3 Find on LinkedIn ↗
-
Sarit Firon · DirectorRehovot, L3 Find on LinkedIn ↗
-
Dan Falk · DirectorRehovot, L3 Find on LinkedIn ↗
-
Adrian Percy · DirectorRehovot, L3 Find on LinkedIn ↗
-
Leon Yehuda Recanati · DirectorRehovot, L3 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗